BRIAN MAHANA: Open Payments
NPI 1902205248 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 26 payments from 9 companies in 2025. Trend: 2023 $804 · 2024 $563 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $208 |
| PFIZER INC. | 14 | $205 |
| Edwards Lifesciences Corporation | 1 | $128 |
| Novo Nordisk Inc | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Abbott Laboratories | 2 | $43 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Boston Scientific Corporation | 1 | $18 |
| Amgen Inc. | 1 | $15 |
Products named: Barostim Neo System, VYNDAQEL, SAPIEN 3 Ultra RESILIA, Wegovy, LEQVIO, CARDIOMEMS, VERQUVO, OPTIS.
Industry payments across AR — which companies pay providers there.
